MRTX Tshuag Surges Ntawm Muaj Peev Xwm Loj Pharma Buyout

Ib tug slew ntawm Big Pharma suitors tuaj yeem nrhiav yuav Mirati Kev Kho Mob (MRTX), raws li cov lus ceeb toom uas xa MRTX Tshuag nyob ze rau qhov kev tawm tsam hnub Wednesday.




X



Bloomberg tau tshaj tawm hnub Tuesday tias Mirati tau txais kev txaus siab ua ntej ntawm cov ntaub ntawv tseem ceeb nyeem lub hlis tom ntej. Cov neeg yuav khoom muaj peev xwm suav nrog Pfizer (PFE), Merck (MRK), Bristol Myers Squibb (BMY) thiab AstraZeneca (AZN).

Mirati tab tom ua haujlwm rau ntau yam kev kho mob qog noj ntshav. Tab sis ntawm cov tub lag luam tseem ceeb txaus siab yog nws cov kev mob qog nqaij hlav qog nqaij hlav me me. Lub tuam txhab tab tom ua haujlwm rau kev kho mob rau cov neeg mob uas muaj kev hloov pauv hauv lawv cov noob KRAS.

On hnub no lub khw lag luam, MRTX Tshuag tau nce 11.3% rau 95.85. Qhov ntawd ua raws li 15.5% pop hnub Tuesday. Shares nqaim tawg tawm ntawm ib khob base nrog ib tug muas point ntawm 95.79, as MarketSmith.com.

MRTX Tshuag: Rivaling Amgen's Pom Zoo Tshuaj

Mirati twb tau ua haujlwm rau kev npaj rau adagrasib, nws txoj kev kho mob ntsws cancer. FDA yuav tsum txiav txim siab seb puas yuav pom zoo adagrasib los ntawm Lub Kaum Ob Hlis 14. Tsis tas li ntawd lub hlis tom ntej, Mirati yuav nthuav tawm cov txiaj ntsig ntawm adagrasib ntxiv rau Merck's Keytruda hauv cov neeg mob qog noj ntshav uas tsis tau kho.

Amgen's (AMGN) Lumakras kuj tsom rau tib qhov kev hloov pauv hauv KRAS gene. Cov kev hloov pauv no muaj kev sib raug zoo rau mob qog noj ntshav thiab muaj, keeb kwm, nyuaj rau lub hom phiaj. Tam sim no Lumakras tau nyob hauv khw rau ntau tshaj ib xyoos.

"Peb xav tias qhov kev pom zoo adagrasib muaj feem ntau dua li qhov tsis yog, thaum lub sijhawm ntawd daim ntawv lo yuav raug tshuaj xyuas hnyav, vim tias cov tub ua lag luam yuav muab piv rau Lumakras daim ntawv lo los txiav txim qhov kev sib tw ntawm tus tshiab nkag rau hauv kev ua lag luam," SVB Securities kws tshuaj ntsuam xyuas Andrew Berens tau hais hauv tsab ntawv ceeb toom tsis ntev los no.

Nws muaj qhov ua tau zoo tshaj plaws ntawm MRTX Tshuag.

Mirati tsis kam tawm tswv yim txog qhov kev xav.

"Peb tau tsav los ntawm kev xav txhim kho cov txiaj ntsig ntawm tus neeg mob thiab tseem tab tom nrhiav rau pem hauv ntej rau ntau lub tuam txhab tseem ceeb tom ntej no nrog rau kev pom zoo ntawm adagrasib rau cov neeg mob NSCLC nrog KRAS G12C kev hloov pauv," tus kws tshaj lij Mirati tau hais hauv email.

MRTX Tshuag muaj qhov muaj zog Ntsuam Xyuas Lub Zog Muaj Zog ua 85, IB Digital. Qhov no ua rau muaj kev sib koom ua ke rau saum 15% ntawm tag nrho cov khoom lag luam hauv 12 lub hlis ua haujlwm.

Ua raws li Allison Gatlin ntawm Twitter ntawm @IBD_AGatlin.

KOJ UA LI CAS:

FDA tsuas yog pom zoo nws cov tshuaj kim tshaj plaws puas tau - Xa UniQure Tshuag ntawm Warpath

Medtronic hits ob-xyoos qis nyob rau lub quarterly Lag - Tab sis cov kws tshuaj ntsuam saib rau qhov ci ntsa iab

Saib IBD Cov Lus Qhia Txog Kev nqis peev qhia rau Kev Ua Lag Luam Kev Pom Zoo

IBD Tshuag Ntawm Hnub: Saib Yuav Tsum Nrhiav Li Cas, Teev Thiab Yuav Cov Khoom Zoo

Xav Tau Txais Nyiaj Tau sai thiab Zam loj los ploj? Sim ua SwingTrader

Tau qhov twg los: https://www.investors.com/news/technology/mrtx-stock-surges-on-potential-big-pharma-buyout/?src=A00220&yptr=yahoo